NBIX. Uptrend. PR after hours. $9.19 Neurocri
Post# of 63824

NBIX. Uptrend. PR after hours. $9.19
Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor


NBIX. Uptrend. PR after hours. $9.19